Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 2/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | FABP3 | P05413 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.38 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.37 |
| ▸ | PTAFR | P25105 | 1/20 | 0.37 |
| ▸ | HTR1D | P28221 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 2/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17084575 | 0.91 | FABP3 (0.48) | PGDLPAR3LPAR1FABP3ENPP2 | |
| SCHEMBL5959467 | 0.89 | PLA2G2C (0.47) | PGDLPAR3LPAR1TDP1FABP3 | |
| SCHEMBL15385430 | 0.89 | SELP (0.42) | PGDLPAR3LPAR1TDP1FABP3 | |
| SCHEMBL23219294 | 0.89 | FABP3 (0.39) | PGDLPAR3LPAR1TDP1FABP3 | |
| SCHEMBL4572659 | 0.89 | PLA2G2C (0.47) | PGDLPAR3LPAR1TDP1FABP3 | |
| SCHEMBL4572661 | 0.89 | SELP (0.49) | PGDLPAR3LPAR1TDP1FABP3 | |
| SCHEMBL5959432 | 0.89 | PGD (0.56) | PGDLPAR3LPAR1TDP1ENPP2 | |
| SCHEMBL4572660 | 0.89 | PGD (0.56) | PGDLPAR3LPAR1TDP1ENPP2 | |
| SCHEMBL30989241 | 0.88 | P2RY10 (0.46) | — | |
| SCHEMBL12888699 | 0.88 | P2RY10 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975111-B2 | Cardiopathy-reducing phosphodiester lipids | SIGNPATH PHARMA, INC. (US) | 2021-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10975111-B2 | Cardiopathy-reducing phosphodiester lipids | TNNT2, TNNI3, FABP3 | PGD 508/4885LPAR3 219/4885LPAR1 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.